David H. Crean

David H. Crean has a long and accomplished history in the business world. David is currently the Chairman at Theirtogen, a position they have held since 2015. Prior to that, they were with Biocom California from 2014-2015, Renaissance Executive Forums from 2012-2014, Phoenix Molecular Designs from 2009-2012, MediciNova, Inc. from 2007-2009, Lenire Biosciences from 2005-2007, Cardiff Advisory LLC from 2003-2005, Forbes Los Angeles Business Council from 2001-2003, and California Life Sciences (CLS) from 1999-2001.

David H. Crean has a Master of Business Administration (MBA) from Pepperdine Graziadio Business School, a Doctor of Philosophy (Ph.D.) in Biophysics from State University of New York at Buffalo - School of Pharmacy and Pharmaceutical Sciences, and a Master of Science (M.S.) in Natural Sciences / Oncology from University at Buffalo. David also has a Bachelor of Science (B.S.) in PreMed & Sports Medicine from Canisius College and is certified by the FINRA (Financial Industry Regulatory Authority) in Series 79 - Investment Banking Representative and Series 63 - Uniform State Law Securities License.